化学化对眼睛协同运动的影响
Corin M Kinkhabwala1, Allie Ottinger1, Tanner Diemer1
1Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Facial plastic surgery & aesthetic medicine
|November 6, 2024
概括
眼肌的化学激活有效地改善了眼开放,在患者的眼睛协同运动. 这种治疗可以提高眼裂的高度,特别是在动态的面部运动期间.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 整形外科 整形外科 整形外科
背景情况:
- 化疗是面部麻患者共动的常见治疗方法.
- 客观数据评估化学化对协的疗效是有限的.
- 眼部协同运动可以显著影响患者的生活质量.
研究的目的:
- 为了客观地测量化疗后眼眼裂高度的变化.
- 为了评估休息状态和自愿面部运动 (puckering) 期间的治疗效果.
- 为了评估orbicularis oculi肌肉化学化对眼部协同运动的影响.
主要方法:
- 在2015年1月至2023年7月期间,对同动因治疗的患者进行了回顾性审查.
- 化学消化剂的向是眼圈肌肉.
- 计算机面部分析 (Emotrics+) 测量了从静止和的照片中掌裂的高度.
主要成果:
- 眼裂高度在休息时增加了1.16毫米 (p=0.014) 和在时增加了2.31毫米 (p<0.01).
- 注射后的平均随访期为37.63天.
- 注射剂量与眼裂高度的变化没有相关性.
结论:
- 眼肌的化疗激活是有效的改善眼裂高度在眼睛的协同运动.
- 与静止状态相比,在动态的面部运动中,治疗显示出更大的效果.
- 客观的摄影分析为评估协同运动治疗结果提供了有价值的数据.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
618
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
618
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.1K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.1K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
693
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
693
Depolarizing Blockers: Mechanism of Action
1.4K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.4K
Cholinergic Antagonists: Therapeutic Uses
716
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
716


